Sign inGet started

ITEK

INOTEK PHARMACEUTICALS CORPCIK 1281895 ☆ Sign in to watchCongress trades
Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
23

AI insights for ITEK PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
AI insights for ITEK
Insider sentiment score with a plain-English explanation, conviction score on every buy, and how the stock performed 30 and 90 days after past insider buys.
Upgrade to Pro · $99/yearAlready Pro? Log in

Daily buy vs sell · 90 days

No data yet.

Insiders

InsiderRoleTradesBoughtSoldLast trade
RITTER DALEVice President, Finance5$0$02017-09-14
Spivey Richard N.Director3$0$02017-06-20
Machado PatrickDirector2$0$02017-06-20
CARROLL J MARTINDirector5$90.3K$02017-06-20
BOESS CARSTENDirector3$0$02017-06-20
HOWES PAUL GDirector3$0$02017-06-20
Phillips Gary M.Director3$0$02017-06-20
BARBERICH TIMOTHY JDirector2$0$02017-06-20
Baumgartner RudolphSee Remarks4$0$02017-01-23
SOUTHWELL DAVID PSee Remarks5$105.0K$02017-01-23
Devon Park Associates, L.P.10% Owner2$0$02017-01-04
McVicar William K.See Remarks2$0$02016-03-22
Rho Ventures IV-A, L.P.10% Owner2$0$02015-11-16
Devon Park Associates, LLC10% Owner7$4.88M$02015-07-14
Harel IttaiDirector1$0$02015-06-24
Peimer IsaiDirector1$0$02015-06-24
VOGELBAUM MARTINDirector1$0$02015-06-24
CARE CAPITAL INVESTMENTS II LP10% Owner6$3.62M$02015-06-24
KARABELAS ARGERIS NDirector, 10% Owner6$3.62M$02015-06-24
RUCH JOSHUA10% Owner5$5.75M$02015-02-23
Kantesaria Devang10% Owner5$4.88M$02015-02-23
MedImmune Ventures, Inc.10% Owner5$2.50M$02015-02-23
Pitango Venture Capital Fund IV, L.P.10% Owner5$1.27M$02015-02-23

Trade history

InsiderRoleCodeTradeFiledSharesPriceValueOwned after
RITTER DALEVice President, Finance M Exercise2017-09-142017-09-1812,500— $019,827SEC↗
Spivey Richard N.Director A Award deriv2017-06-202017-06-2145,000— $045,000SEC↗
Machado PatrickDirector A Award deriv2017-06-202017-06-2145,000— $045,000SEC↗
CARROLL J MARTINDirector A Award deriv2017-06-202017-06-2145,000— $045,000SEC↗
Phillips Gary M.Director A Award deriv2017-06-202017-06-2145,000— $045,000SEC↗
HOWES PAUL GDirector A Award deriv2017-06-202017-06-2145,000— $045,000SEC↗
BOESS CARSTENDirector A Award deriv2017-06-202017-06-2145,000— $045,000SEC↗
BARBERICH TIMOTHY JDirector A Award deriv2017-06-202017-06-2145,000— $045,000SEC↗
Baumgartner Rudolf ASee Remarks A Award deriv2017-01-232017-01-24175,000— $0175,000SEC↗
Baumgartner Rudolf ASee Remarks A Award deriv2017-01-232017-01-24120,000— $0120,000SEC↗
SOUTHWELL DAVID PPresident and CEO A Award deriv2017-01-232017-01-24350,000— $0350,000SEC↗
SOUTHWELL DAVID PPresident and CEO A Award deriv2017-01-232017-01-24350,000— $0350,000SEC↗
RITTER DALEVice President, Finance M Exercise deriv2017-01-172017-09-1812,500— $037,500SEC↗
RITTER DALEVice President, Finance A Award deriv2017-01-172017-01-1950,000— $050,000SEC↗
SOUTHWELL DAVID PPresident and CEO P Buy2017-01-062017-01-0960,000$1.75 $105.0K62,765SEC↗
Devon Park Associates, L.P.10% Owner J Other2017-01-042017-01-069,857— $00SEC↗
Devon Park Associates, L.P.10% Owner J Other2017-01-042017-01-063,243,709— $09,857SEC↗
BARBERICH TIMOTHY JDirector A Award deriv2016-09-282016-09-2924,000— $024,000SEC↗
Machado PatrickDirector A Award deriv2016-08-172016-08-1824,000— $024,000SEC↗
Spivey Richard N.Director A Award deriv2016-06-232016-06-2712,000— $012,000SEC↗
HOWES PAUL GDirector A Award deriv2016-06-232016-06-2712,000— $012,000SEC↗
CARROLL J MARTINDirector A Award deriv2016-06-232016-06-2712,000— $012,000SEC↗
CARROLL J MARTINDirector A Award deriv2016-06-232016-06-2751,000— $051,000SEC↗
BOESS CARSTENDirector A Award deriv2016-06-232016-06-2712,000— $012,000SEC↗
Phillips Gary M.Director A Award deriv2016-06-232016-06-2712,000— $012,000SEC↗
CARROLL J MARTINDirector P Buy2016-05-132016-05-1710,000$9.03 $90.3K10,000SEC↗
CARROLL J MARTINDirector A Award deriv2016-04-012016-04-0424,000— $024,000SEC↗
SOUTHWELL DAVID PSee Remarks A Award deriv2016-03-222016-03-24215,000— $0215,000SEC↗
McVicar William K.See Remarks A Award deriv2016-03-222016-03-24135,000— $0135,000SEC↗
Baumgartner RudolphSee Remarks A Award deriv2016-03-222016-03-24165,000— $0165,000SEC↗
RITTER DALEVice President, Finance A Award deriv2016-03-222016-03-2440,000— $040,000SEC↗
BOESS CARSTENDirector A Award deriv2016-01-112016-01-1224,000— $024,000SEC↗
Rho Ventures IV-A, L.P.10% Owner J Other2015-11-162015-11-18115,083— $0636,496SEC↗
Rho Ventures IV-A, L.P.10% Owner J Other2015-11-162015-11-18127,711— $00SEC↗
Phillips Gary M.Director A Award deriv2015-10-132015-10-1324,000— $024,000SEC↗
Spivey Richard N.Director A Award deriv2015-07-162015-07-2024,000— $024,000SEC↗
Devon Park Associates, LLC10% Owner M Exercise deriv2015-07-142015-07-169,857— $00SEC↗
Devon Park Associates, LLC10% Owner M Exercise2015-07-142015-07-169,857$4.34 $42.8K3,253,566SEC↗
Harel IttaiDirector A Award deriv2015-06-242015-06-2612,000$5.03 $60.4K21,857SEC↗
Baumgartner RudolphSee Remarks A Award deriv2015-06-242015-06-2675,000$5.03 $377.3K276,615SEC↗
HOWES PAUL GDirector A Award deriv2015-06-242015-06-2612,000$5.03 $60.4K28,017SEC↗
McVicar William K.See Remarks A Award deriv2015-06-242015-06-2675,000$5.03 $377.3K276,094SEC↗
KARABELAS ARGERIS NDirector, 10% Owner A Award deriv2015-06-242015-06-2612,000$5.03 $60.4K21,857SEC↗
RITTER DALEVice President, Finance A Award deriv2015-06-242015-06-2625,000$5.03 $125.8K68,982SEC↗
VOGELBAUM MARTINDirector A Award deriv2015-06-242015-06-2612,000$5.03 $60.4K21,857SEC↗
Peimer IsaiDirector A Award deriv2015-06-242015-06-2612,000$5.03 $60.4K21,857SEC↗
SOUTHWELL DAVID PSee Remarks A Award deriv2015-06-242015-06-26150,000$5.03 $754.5K548,497SEC↗
CARE CAPITAL INVESTMENTS II LP10% Owner A Award deriv2015-06-242015-06-2612,000$5.03 $60.4K21,857SEC↗
MedImmune Ventures, Inc.10% Owner C Conversion deriv2015-02-232015-02-25338,551— $00SEC↗
MedImmune Ventures, Inc.10% Owner C Conversion deriv2015-02-232015-02-254,013,692— $00SEC↗
Devon Park Associates, LLC10% Owner C Conversion deriv2015-02-232015-02-257,432,720— $00SEC↗
Devon Park Associates, LLC10% Owner C Conversion deriv2015-02-232015-02-25626,943— $00SEC↗
Kantesaria Devang10% Owner C Conversion deriv2015-02-232015-02-257,432,720— $00SEC↗
Kantesaria Devang10% Owner C Conversion deriv2015-02-232015-02-25626,943— $00SEC↗
RUCH JOSHUA10% Owner C Conversion deriv2015-02-232015-02-25432,591— $00SEC↗
RUCH JOSHUA10% Owner C Conversion deriv2015-02-232015-02-255,128,577— $00SEC↗
CARE CAPITAL INVESTMENTS II LP10% Owner C Conversion deriv2015-02-232015-02-250— $00SEC↗
CARE CAPITAL INVESTMENTS II LP10% Owner C Conversion deriv2015-02-232015-02-254,459,658— $00SEC↗
KARABELAS ARGERIS NDirector, 10% Owner C Conversion deriv2015-02-232015-02-250— $00SEC↗
KARABELAS ARGERIS NDirector, 10% Owner C Conversion deriv2015-02-232015-02-254,459,658— $00SEC↗
Pitango Venture Capital Fund I10% Owner C Conversion deriv2015-02-232015-02-25225,747— $00SEC↗
Pitango Venture Capital Fund I10% Owner C Conversion deriv2015-02-232015-02-252,676,348— $00SEC↗
MedImmune Ventures, Inc.10% Owner C Conversion2015-02-232015-02-251,255,123— $01,444,035SEC↗
MedImmune Ventures, Inc.10% Owner P Buy2015-02-232015-02-25416,667$6.00 $2.50M1,917,906SEC↗
MedImmune Ventures, Inc.10% Owner C Conversion2015-02-232015-02-2557,204— $01,501,239SEC↗
Devon Park Associates, LLC10% Owner P Buy2015-02-232015-02-25814,166$6.00 $4.88M3,243,709SEC↗
Devon Park Associates, LLC10% Owner C Conversion2015-02-232015-02-25105,933— $02,429,543SEC↗
Devon Park Associates, LLC10% Owner C Conversion2015-02-232015-02-252,323,610— $02,323,610SEC↗
Kantesaria Devang10% Owner C Conversion2015-02-232015-02-25105,933— $02,429,543SEC↗
Kantesaria Devang10% Owner C Conversion2015-02-232015-02-252,323,610— $02,323,610SEC↗
Kantesaria Devang10% Owner P Buy2015-02-232015-02-25814,166$6.00 $4.88M3,243,709SEC↗
RUCH JOSHUA10% Owner P Buy2015-02-232015-02-25958,226$6.00 $5.75M2,870,584SEC↗
RUCH JOSHUA10% Owner C Conversion2015-02-232015-02-2573,092— $01,912,358SEC↗
RUCH JOSHUA10% Owner C Conversion2015-02-232015-02-251,606,230— $01,839,266SEC↗
CARE CAPITAL INVESTMENTS II LP10% Owner C Conversion2015-02-232015-02-2563,560— $01,673,307SEC↗
CARE CAPITAL INVESTMENTS II LP10% Owner P Buy2015-02-232015-02-25603,832$6.00 $3.62M2,277,139SEC↗
CARE CAPITAL INVESTMENTS II LP10% Owner C Conversion2015-02-232015-02-251,394,645— $01,609,747SEC↗
KARABELAS ARGERIS NDirector, 10% Owner C Conversion2015-02-232015-02-251,394,645— $01,609,747SEC↗
KARABELAS ARGERIS NDirector, 10% Owner P Buy2015-02-232015-02-25603,832$6.00 $3.62M2,277,139SEC↗
KARABELAS ARGERIS NDirector, 10% Owner C Conversion2015-02-232015-02-2563,560— $01,673,307SEC↗
Pitango Venture Capital Fund I10% Owner P Buy2015-02-232015-02-25212,375$6.00 $1.27M1,292,584SEC↗
Pitango Venture Capital Fund I10% Owner C Conversion2015-02-232015-02-2538,143— $01,080,209SEC↗
Pitango Venture Capital Fund I10% Owner C Conversion2015-02-232015-02-25847,424— $01,042,066SEC↗